MASH may require personalized treatment as distinct disease subtypes emerge
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, affecting an estimated 38% of adults worldwide. Its progressive form, MASH, is characterized by inflammation and damage to liver cells and can lead to liver cirrhosis and liver cancer, among other complications. MASH is also becoming an increasingly important reason for liver…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
